GILD

Gilead Sciences, Inc. News Headlines

$107.56
*  
0.05
0.05%
Get GILD Alerts
*Delayed - data as of Aug. 29, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Strength Seen in Cara Therapeutics Inc. (CARA) as Stock Rallies 19.60% - Tale of the Tape
6/23/2014 8:44:00 AM - Zacks.com

AstraZeneca's Naloxegol Data Published - Analyst Blog
6/20/2014 6:00:00 PM - Zacks.com

Dividend Yield Vs. Dividend Growth Revisited - Does It Matter?
6/20/2014 4:26:00 PM - Seeking Alpha

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 3:50:00 PM - Zacks.com

Merge Healthcare: Updated Research Report - Analyst Blog
6/20/2014 2:55:00 PM - Zacks.com

Illumina: Updated Research Report - Analyst Blog
6/20/2014 2:30:00 PM - Zacks.com

Celgene Rises on Yet Another Stock Split - Analyst Blog
6/20/2014 11:30:00 AM - Zacks.com

Cubist Gets Priority Review from FDA for Antibiotic Candidate - Analyst Blog
6/20/2014 11:00:00 AM - Zacks.com

Speculators On The Next HCV Acquisition Should Not Overlook Technological Platforms
6/20/2014 10:25:00 AM - Seeking Alpha

Cramer's Lightning Round - I Always Come Back To Palo Alto Networks (6/19/14)
6/20/2014 6:35:00 AM - Seeking Alpha

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog
6/19/2014 6:15:00 PM - Zacks.com

BioLineRx to Commence BL-8040 Study - Analyst Blog
6/19/2014 6:10:00 PM - Zacks.com

Valeant Launches Hostile Bid for Allergan - Analyst Blog
6/19/2014 5:50:00 PM - Zacks.com

Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug - Analyst Blog
6/19/2014 5:00:00 PM - Zacks.com

Insmed Soars on Arikayce's Breakthrough Designation - Analyst Blog
6/19/2014 4:30:00 PM - Zacks.com

Forest Laboratories Nabs Pediatric Exclusivity for Namenda - Analyst Blog
6/19/2014 1:20:00 PM - Zacks.com

Alkermes' Aripiprazole Lauroxil Looks Promising - Analyst Blog
6/19/2014 11:40:00 AM - Zacks.com

Ultragenyx Pharmaceutical (RARE) Jumps: Stock Up 6.5% - Tale of the Tape
6/19/2014 9:39:00 AM - Zacks.com

Insmed Incorporated (INSM) Catches Eye: Stock Surges 42.6% - Tale of the Tape
6/19/2014 9:32:00 AM - Zacks.com

Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape
6/19/2014 9:25:00 AM - Zacks.com

Acorda Therapeutics (ACOR) in Focus: Stock Moves 7.8% Higher - Tale of the Tape
6/19/2014 9:18:00 AM - Zacks.com

Applied Genetic Technologies (AGTC) Jumps: Stock Up 6.1% - Tale of the Tape
6/19/2014 9:04:00 AM - Zacks.com

Intra-Cellular Therapies, Inc. (ITCI) in Focus: Stock Rises 8.74% - Tale of the Tape
6/19/2014 8:44:00 AM - Zacks.com

Sovaldi And Drug Pricing: The United States Of Saps
6/19/2014 3:36:00 AM - Seeking Alpha

Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
6/18/2014 6:15:00 PM - Zacks.com